Remote monitoring has been associated with improved survival. Patients with high remote monitoring adherence see a 53-percent greater survival than patients with low remote monitoring adherence and a 140-percent greater survival than patients not using remote monitoring at all. Additional studies have shown the following clinical outcomes:
ENABLING EARLY INTERVENTION OF AF TO HELP YOU MINIMIZE THE RISK OF STROKE
ATRIAL FIBRILLATION IS RELATED TO AN INCREASED RISK OF STROKEWhile our clinical evidence shows a range of benefits for patients who properly utilize remote monitoring, our clinical studies demonstrate especially strong evidence for the role of remote monitoring in early stroke intervention.
Medical experts have known about the strong relationship between atrial fibrillation (AF) and stroke since the 1970s. Early detection of AF allows for early intervention. Remote monitoring can enable early intervention, allowing for appropriate therapy to minimize the risk of stroke.
EARLY INTERVENTION OF STROKE THROUGH TIMELY NOTIFICATION OF AF
Implanted devices allow health care professionals to assess the burden of AF by tracking the number and duration of symptomatic and asymptomatic AF episodes.
With the information provided by such devices, coupled with remote care, you may detect subclinical episodes, which may result in early intervention and potentially improved outcomes. The following studies summarize the potential benefit of remote care.
EFFICACY OF STROKE PREVENTION
Early intervention with appropriate pharmacological therapy in AF can reduce the risk of stroke. Numerous clinical trials have provided an extensive evidence base for the use of antithrombotic therapy in AF. A meta-analysis of 29 trials including 28,044 participants was conducted to characterize the efficacy and safety of antithrombotic agents for stroke prevention in patients who have AF. Of these trials, six evaluated the effect of adjusted-dose warfarin and cumulatively showed that adjusted-dose warfarin reduced stroke by 64 percent.